title: Biosimilars to treat inflammatory arthritis: the challenge of proving identity.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Kay
authors.forename: Josef S
authors.initials: JS
authors.lastname: Smolen
mesh_terms: D000911:Antibodies, Monoclonal / Q000097:blood* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000097:blood* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood* / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D013167:Spondylitis, Ankylosing / Q000097:blood*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D000069285:Infliximab; D008727:Methotrexate
keywords: Ankylosing Spondylitis; Anti-TNF; Pharmacokinetics; Rheumatoid Arthritis; Treatment